Peptris Technologies gets ₹86 crore grant and ₹70 crore Series A
In short
Peptris Technologies, a Bengaluru startup, has received an ₹86 crore government grant and ₹70 crore in Series A funding. It says it will use generative AI to build a preclinical pipeline for rare diseases and hard-to-treat proteins.
This matters because the money could help the company advance its drug research. The reporting does not say when any drug candidates may move forward or who the investors are.
What the reporting says
Peptris Technologies, a Bengaluru startup, received an ₹86 crore government grant and ₹70 crore in Series A funding to build a preclinical pipeline using generative AI. The reporting says the company is targeting rare diseases and previously undruggable proteins. What remains unknown is the timing of any clinical progress, investor details, or regulatory milestones.
Why it matters
Peptris Technologies secured an ₹86 crore government grant and ₹70 crore in Series A funding to support a preclinical pipeline built with generative AI. The company is focused on rare diseases and proteins described as previously undruggable. The development matters for biotech, startup financing, and healthcare innovation in Bengaluru, but the reporting does not state the funders, timeline, or any clinical outcomes.